XML 17 R5.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statements of Changes in Convertible Preferred Stoc and Stockholders' Equity (Deficit) (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
AOCI Attributable to Parent [Member]
Retained Earnings [Member]
Total
Balance (in shares) at Dec. 31, 2022 3,331,201 518,140        
Balance at Dec. 31, 2022 $ 24,287,211 $ 518 $ 18,983,339   $ (52,268,916) $ (33,285,059)
Stock-based compensation expense 0 0 242,660   0 242,660
Net unrealized loss on marketable securities           0
Net loss $ 0 $ 0 0   190,525 190,525
Issuance of common stock, prefunded warrants and common stock warrants, net of offering costs (in shares) 0 63,422        
Issuance of common stock, prefunded warrants and common stock warrants, net of offering costs $ 0 $ 63 809,937   0 810,000
Conversion of convertible preferred stock to common stock (in shares) (3,331,201)          
Conversion of convertible preferred stock to common stock $ (24,287,211)          
Conversion of convertible preferred stock to common stock (in shares)   2,936,566        
Conversion of convertible preferred stock to common stock   $ 2,937 24,284,274   0 24,287,211
Issuance of common stock upon settlement of convertible notes (in shares) 0 795,905        
Issuance of common stock upon settlement of convertible notes $ 0 $ 796 6,988,953   0 6,989,749
Issuance of common stock to Diffusion stockholders in reverse capitalization, net of issuance costs (in shares) 0 1,360,244        
Issuance of common stock to Diffusion stockholders in reverse capitalization, net of issuance costs $ 0 $ 1,360 10,337,754   0 10,339,114
Stock-based compensation expense, including vesting of RSUs (in shares)   77        
Balance (in shares) at Sep. 30, 2023 0 5,674,354        
Balance at Sep. 30, 2023 $ 0 $ 5,674 61,646,917   (52,078,391) 9,574,200
Balance (in shares) at Jun. 30, 2023 3,331,201 518,140        
Balance at Jun. 30, 2023 $ 24,287,211 $ 518 19,116,831   (54,228,753) (35,111,404)
Stock-based compensation expense 0 0 109,168   0 109,168
Net unrealized loss on marketable securities           0
Net loss $ 0 $ 0 0   2,150,362 2,150,362
Issuance of common stock, prefunded warrants and common stock warrants, net of offering costs (in shares) 0 63,422        
Issuance of common stock, prefunded warrants and common stock warrants, net of offering costs $ 0 $ 63 809,937   0 810,000
Conversion of convertible preferred stock to common stock (in shares) (3,331,201)          
Conversion of convertible preferred stock to common stock $ (24,287,211)          
Conversion of convertible preferred stock to common stock (in shares)   2,936,566        
Conversion of convertible preferred stock to common stock   $ 2,937 24,284,274   0 24,287,211
Issuance of common stock upon settlement of convertible notes (in shares) 0 795,905        
Issuance of common stock upon settlement of convertible notes $ 0 $ 796 6,988,953   0 6,989,749
Issuance of common stock to Diffusion stockholders in reverse capitalization, net of issuance costs (in shares) 0 1,360,244        
Issuance of common stock to Diffusion stockholders in reverse capitalization, net of issuance costs $ 0 $ 1,360 10,337,754   0 10,339,114
Stock-based compensation expense, including vesting of RSUs (in shares)   77        
Balance (in shares) at Sep. 30, 2023 0 5,674,354        
Balance at Sep. 30, 2023 $ 0 $ 5,674 61,646,917   (52,078,391) 9,574,200
Balance (in shares) at Dec. 31, 2023 0 5,674,520        
Balance at Dec. 31, 2023 $ 0 $ 5,674 61,811,889 $ 0 (54,440,789) 7,376,774
Stock-based compensation expense 0 0 1,068,011 0 0 1,068,011
Net unrealized loss on marketable securities   0 0 123,162 0 123,162
Net loss 0 $ 0 0 0 (9,584,781) (9,584,781)
Issuance of common stock, prefunded warrants and common stock warrants, net of offering costs (in shares)   2,083,262        
Issuance of common stock, prefunded warrants and common stock warrants, net of offering costs   $ 2,083 46,396,523 0 0 46,398,606
Stock options granted in lieu of compensation $ 0 $ 0 255,724 0 0 255,724
Cashless exercise of prefunded warrants (in shares) 0 495,959        
Cashless exercise of prefunded warrants $ 0 $ 496 (496) 0 0 0
Conversion of convertible preferred stock to common stock           0
Balance (in shares) at Sep. 30, 2024 0 8,253,741        
Balance at Sep. 30, 2024 $ 0 $ 8,253 109,531,651 123,162 (64,025,570) 45,637,496
Balance (in shares) at Jun. 30, 2024 0 8,253,741        
Balance at Jun. 30, 2024 $ 0 $ 8,253 109,260,436 (19,702) (59,272,029) 49,976,958
Stock-based compensation expense 0 0 271,215 0 0 271,215
Net unrealized loss on marketable securities 0 0 0 142,864 0 142,864
Net loss $ 0 $ 0 0 0 (4,753,541) (4,753,541)
Balance (in shares) at Sep. 30, 2024 0 8,253,741        
Balance at Sep. 30, 2024 $ 0 $ 8,253 $ 109,531,651 $ 123,162 $ (64,025,570) $ 45,637,496